Blue Biofuels Inc Financials
This page shows Blue Biofuels Inc (BIOF) financial statements, including the income statement, balance sheet, cash flow statement, and key financial ratios. View 12 years of annual fundamentals and quarterly data, with year-over-year growth rates and compound annual growth rates (CAGR). All figures are derived from SEC filings (10-K and 10-Q reports).
A research-led cost base and persistent cash burn make external financing the company’s main source of continuity.
Operating cash burn improved to-$845K in FY2025 from-$1.0M in FY2024. Yet operating loss remained around-$3.7M , so accounting losses are running far ahead of cash use; that usually reflects a mix of non-cash charges and a cost structure that still lacks self-funding scale.
External financing is functioning as the operating bridge: FY2025 financing inflow of
This is a low-capital-intensity setup: capital spending was only
Financial Health Signals
Based on FY2025 annual data, averaged across the last 3 years for performance metrics (most-recent year weighted highest). How this score is calculated →
Health score ≠ stock price. This rates the quality of Blue Biofuels Inc's business: profitability, growth, balance sheet strength. It doesn't tell you whether the stock is a good buy at today's price. Not financial advice. Use it alongside valuation analysis and your own research.
Blue Biofuels Inc has elevated debt relative to equity (D/E of -1.38), meaning the company relies heavily on borrowed funds. This high leverage results in a low score of 2/100, reflecting increased financial risk.
Blue Biofuels Inc's current ratio of 0.03 is below the typical benchmark, resulting in a score of 0/100. This tight liquidity could limit financial flexibility if cash inflows slow.
Blue Biofuels Inc passes 1 of 9 financial strength tests. 1 of 4 profitability signals pass, no leverage/liquidity signals pass (rising debt, declining liquidity, or share dilution).
For every $1 of reported earnings, Blue Biofuels Inc generates $0.29 in operating cash flow (-$845K OCF vs -$2.9M net income). This low ratio suggests earnings are primarily driven by accounting accruals rather than cash generation, which may not be sustainable.
Key Financial Metrics
Earnings & Revenue
Blue Biofuels Inc's EBITDA was -$3.6M in fiscal year 2025, measuring earnings before interest, taxes, depreciation, and amortization. This represents an increase of 9.4% from the prior year.
Blue Biofuels Inc reported -$2.9M in net income in fiscal year 2025. This represents a decrease of 102.6% from the prior year.
Blue Biofuels Inc earned $-0.01 per diluted share (EPS) in fiscal year 2025. This represents a decrease of 80.0% from the prior year.
Cash & Balance Sheet
Blue Biofuels Inc generated -$914K in free cash flow in fiscal year 2025, representing cash available after capex. This represents an increase of 15.0% from the prior year.
Blue Biofuels Inc held $65K in cash against $0 in long-term debt as of fiscal year 2025.
Blue Biofuels Inc had 318M shares outstanding in fiscal year 2025. This represents an increase of 3.2% from the prior year.
Margins & Returns
Capital Allocation
Blue Biofuels Inc invested $2.3M in research and development in fiscal year 2025. This represents a decrease of 1.0% from the prior year.
Blue Biofuels Inc invested $69K in capex in fiscal year 2025, funding long-term assets and infrastructure. This represents a decrease of 3.1% from the prior year.
BIOF Income Statement
| Metric | Q1'26 | Q4'25 | Q3'25 | Q2'25 | Q1'25 | Q4'24 | Q3'24 | Q2'24 |
|---|---|---|---|---|---|---|---|---|
| Revenue | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Cost of Revenue | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Gross Profit | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| R&D Expenses | $385K | N/A | $486K+3.0% | $471K+34.4% | $351K | N/A | $411K+41.0% | $291K |
| SG&A Expenses | $275K | N/A | $351K-18.7% | $431K+27.5% | $338K | N/A | $237K-5.1% | $250K |
| Operating Income | -$659K | N/A | -$836K+7.4% | -$903K-31.0% | -$689K | N/A | -$648K-19.7% | -$541K |
| Interest Expense | $4K | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Income Tax | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Net Income | -$664K | N/A | -$423K+54.1% | -$921K-277.6% | -$244K | N/A | $1.9M+440.0% | -$549K |
| EPS (Diluted) | $-0.00 | N/A | $-0.00+66.7% | $-0.00-200.0% | $-0.00 | N/A | $0.01+400.0% | $-0.00 |
BIOF Balance Sheet
| Metric | Q1'26 | Q4'25 | Q3'25 | Q2'25 | Q1'25 | Q4'24 | Q3'24 | Q2'24 |
|---|---|---|---|---|---|---|---|---|
| Total Assets | $1.3M-6.9% | $1.4M-5.3% | $1.5M+2.6% | $1.4M-2.3% | $1.5M+6.7% | $1.4M-6.7% | $1.5M+14.1% | $1.3M |
| Current Assets | $20K-73.7% | $77K-28.0% | $107K+447.5% | $19K-51.4% | $40K-50.7% | $81K-62.4% | $216K-50.9% | $440K |
| Cash & Equivalents | $9K-86.7% | $65K-31.5% | $95K+1086.1% | $8K+5.8% | $8K-84.5% | $49K-67.3% | $149K-63.4% | $408K |
| Inventory | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Accounts Receivable | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Goodwill | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Total Liabilities | $5.2M+2.6% | $5.1M+12.5% | $4.5M-1.7% | $4.6M+4.2% | $4.4M+4.7% | $4.2M+5.9% | $4.0M-34.0% | $6.1M |
| Current Liabilities | $3.1M+4.5% | $3.0M+24.7% | $2.4M-2.3% | $2.5M+5.2% | $2.3M+5.3% | $2.2M+12.9% | $2.0M-1.5% | $2.0M |
| Long-Term Debt | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Total Equity | -$3.9M-6.2% | -$3.7M-21.2% | -$3.1M+3.6% | -$3.2M-7.5% | -$3.0M-3.7% | -$2.8M-13.3% | -$2.5M+47.1% | -$4.8M |
| Retained Earnings | -$60.8M-1.1% | -$60.1M-2.2% | -$58.8M-0.7% | -$58.4M-1.6% | -$57.5M-0.4% | -$57.3M-3.2% | -$55.5M+3.3% | -$57.3M |
BIOF Cash Flow Statement
| Metric | Q1'26 | Q4'25 | Q3'25 | Q2'25 | Q1'25 | Q4'24 | Q3'24 | Q2'24 |
|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow | -$419K-6.7% | -$392K-154.8% | -$154K+50.7% | -$312K-2426.6% | $13K+106.3% | -$212K+14.5% | -$248K+13.7% | -$288K |
| Capital Expenditures | $105K+10463100.0% | -$1+100.0% | -$67K-313.4% | $32K-69.9% | $105K | N/A | N/A | N/A |
| Free Cash Flow | -$523K-33.4% | -$392K-77.3% | -$221K+35.6% | -$344K-276.8% | -$91K | N/A | N/A | N/A |
| Investing Cash Flow | -$10K+1.8% | -$10K-115.4% | $66K+271.0% | -$39K+75.0% | -$155K-80.7% | -$86K-722.3% | -$10K-1140.5% | $1K |
| Financing Cash Flow | $372K-0.1% | $373K+112.9% | $175K-50.2% | $351K+251.3% | $100K-49.2% | $197K | $0-100.0% | $670K |
| Dividends Paid | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Share Buybacks | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
BIOF Financial Ratios
| Metric | Q1'26 | Q4'25 | Q3'25 | Q2'25 | Q1'25 | Q4'24 | Q3'24 | Q2'24 |
|---|---|---|---|---|---|---|---|---|
| Gross Margin | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Operating Margin | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Net Margin | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Return on Equity | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Return on Assets | -50.7% | N/A | -28.4%+35.2pp | -63.6%-47.1pp | -16.4% | N/A | 125.3%+167.4pp | -42.0% |
| Current Ratio | 0.01-0.0 | 0.03-0.0 | 0.04+0.0 | 0.010.0 | 0.02-0.0 | 0.04-0.1 | 0.11-0.1 | 0.22 |
| Debt-to-Equity | -1.33+0.0 | -1.38+0.1 | -1.49-0.0 | -1.46+0.0 | -1.50-0.0 | -1.49+0.1 | -1.59-0.3 | -1.27 |
| FCF Margin | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Note: Shareholder equity is negative (-$3.7M), which causes debt-to-equity and return on equity ratios to appear negative or not meaningful. This can occur from accumulated losses or large share buyback programs.
Note: The current ratio is below 1.0 (0.03), indicating current liabilities exceed current assets, which may suggest potential short-term liquidity concerns.
Similar Companies
Frequently Asked Questions
Is Blue Biofuels Inc profitable?
No, Blue Biofuels Inc (BIOF) reported a net income of -$2.9M in fiscal year 2025.
What is Blue Biofuels Inc's EBITDA?
Blue Biofuels Inc (BIOF) had EBITDA of -$3.6M in fiscal year 2025, measuring earnings before interest, taxes, depreciation, and amortization.
What is Blue Biofuels Inc's free cash flow?
Blue Biofuels Inc (BIOF) generated -$914K in free cash flow during fiscal year 2025. This represents a 15.0% change compared to the previous fiscal year. Free cash flow represents the cash a company generates after accounting for capital expenditures, and is widely used to assess financial flexibility and shareholder value.
What is Blue Biofuels Inc's operating cash flow?
Blue Biofuels Inc (BIOF) generated -$845K in operating cash flow during fiscal year 2025, representing cash generated from core business activities.
What are Blue Biofuels Inc's total assets?
Blue Biofuels Inc (BIOF) had $1.4M in total assets as of fiscal year 2025, including both current and long-term assets.
What are Blue Biofuels Inc's capital expenditures?
Blue Biofuels Inc (BIOF) invested $69K in capital expenditures during fiscal year 2025, funding long-term assets and infrastructure.
How much does Blue Biofuels Inc spend on research and development?
Blue Biofuels Inc (BIOF) invested $2.3M in research and development during fiscal year 2025.
What is Blue Biofuels Inc's current ratio?
Blue Biofuels Inc (BIOF) had a current ratio of 0.03 as of fiscal year 2025, which is below 1.0, which may suggest potential liquidity concerns.
What is Blue Biofuels Inc's debt-to-equity ratio?
Blue Biofuels Inc (BIOF) had a debt-to-equity ratio of -1.38 as of fiscal year 2025, measuring the company's financial leverage by comparing total debt to shareholder equity.
What is Blue Biofuels Inc's return on assets (ROA)?
Blue Biofuels Inc (BIOF) had a return on assets of -204.3% for fiscal year 2025, measuring how efficiently the company uses its assets to generate profit.
What is Blue Biofuels Inc's cash runway?
Based on fiscal year 2025 data, Blue Biofuels Inc (BIOF) had $65K in cash against an annual operating cash burn of $845K. This gives an estimated cash runway of approximately 1 months at the current burn rate. Cash runway measures how long a company can continue operating before running out of cash, assuming no additional funding.
Why is Blue Biofuels Inc's debt-to-equity ratio negative or unusual?
Blue Biofuels Inc (BIOF) has negative shareholder equity of -$3.7M as of fiscal year 2025, which causes the debt-to-equity ratio to appear negative or not meaningful. This can occur when accumulated losses exceed invested capital, or after large share buyback programs. Other solvency metrics like the current ratio or interest coverage may be more informative.
What is Blue Biofuels Inc's Piotroski F-Score?
Blue Biofuels Inc (BIOF) has a Piotroski F-Score of 1 out of 9, indicating weak financial health. The F-Score evaluates nine binary signals across profitability (positive ROA, positive cash flow, improving ROA, earnings quality), leverage (decreasing debt, improving liquidity, no share dilution), and operating efficiency (improving gross margin, improving asset turnover). Scores of 7 to 9 indicate strong and improving fundamentals. Learn more in our complete guide to financial health indicators.
Are Blue Biofuels Inc's earnings high quality?
Blue Biofuels Inc (BIOF) has an earnings quality ratio of 0.29x, considered low quality (accrual-driven). This ratio compares operating cash flow to net income. A ratio above 1.0x means the company generates more cash than its reported earnings, indicating sustainable, cash-backed profits. Ratios below 1.0x suggest earnings rely on accounting accruals rather than actual cash generation. Learn more in our complete guide to financial health indicators.
How financially healthy is Blue Biofuels Inc?
Blue Biofuels Inc (BIOF) scores 0 out of 100 on our Financial Profile, indicating weak overall financial health. This composite score evaluates six dimensions: profitability (operating margin), revenue growth, leverage (debt-to-equity), liquidity (current ratio), cash flow quality (free cash flow margin), and shareholder returns (return on equity). Each dimension is normalized against standard financial benchmarks. Learn more in our complete guide to financial health indicators.